Navigation Search

SALIENTVALUE


7 Insights On Why I/DD M+A Has Just Begun

by Tom Schramski, PhD, CMAA and Joshua Boynton, CMAA Volume 5 Issue 11, May 22, 2018  Just 50 years ago nearly 200,000 people with I/DD were locked up in large institutions across the US. Today, about 27,000 people with I/DD live in such environments, including skilled nursing facilities (SNFs) and other similar institutions. This exodus into…

READ MORE

9 Factors That Are Accelerating Consolidation In US Healthcare

by Tom Schramski, PhD, CMAA Volume 5 Issue 10, May 8, 2018  You cannot escape it, not if you have eyes and ears. The US healthcare market is obsessed with consolidation. Optum (insurance) has acquired Surgical Care Affiliates (ambulatory surgery centers), Cigna (insurance) intends to take over CVS (retail pharmacies) and Express Scripts (pharmacy benefits management),…

READ MORE


5 Reasons Why Consumer Direction Is The #1 Factor In The New I/DD Marketplace

by Tom Schramski, PhD, CMAA and Joshua Boynton, CMAA Volume 5 Issue 8, April 10, 2018  In its purest form, consumer direction means that people have significant decision-making control over the services and products they receive. Most people believe this is a right that we can exercise in whatever marketplace we enter – buying a car,…

READ MORE

8 Ways DME Companies Can Thrive In Tough Times

By Bradley M. Smith, ATP, CMAA and Hilsman Knight, CMAA Volume 5 Issue 7, March 27, 2018  Several years ago, DME competitive bidding was instituted by Medicare and the impact has been dramatic. Many smaller DMEs that could not successfully compete sold their assets, restructured their business, or simply closed their doors. Other DME companies, however, saw an…

READ MORE

6 Reasons Why SUD Referrals Are Headed The Outpatient Way

By Tom Schramski, PhD, CMAA Volume 5 Issue 6, March 13, 2018  Nearly 50 years ago, Anais Nin wrote that “we don’t see things as they are, we see things as we are.” Her observation about human projection fits well for the Substance Use Disorder (SUD) market, where we are in the midst of continuing evolution. One of…

READ MORE

6 Great Reasons Healthcare IT Entrepreneurs Should Go With A Financial Partner For The Whole Enchilada

By Bradley Smith, ATP, CMAA and Hilsman Knight Volume 5 Issue 5, February 27, 2018  Today, financial buyers, especially private equity groups (PEGs), are competing pedal-to-the-metal with strategic buyers for quality healthcare IT deals. Healthcare IT companies are at the forefront of these heated competitions, as they seek all-time-high valuations from financial and strategic pursuers alike. While strategic…

READ MORE

Trends Are A Dime A Dozen, High Value Healthcare Companies Are Not

By Tom Schramski, PhD, CMAA Volume 5 Issue 4, February 13, 2018  The language of today’s healthcare marketplace is infused with the word “trends” – reimbursement trends, trends in innovation, managed care trends, and trends of EBITDA multiples for acquisitions in healthcare. We seemingly cannot escape the self-delusion of perfect timing and prediction. Leaders of the most…

READ MORE

7 Key Healthcare Value Drivers in 2018

By David Coit, DBA, CVA, CVGA, CMAA Volume 5 Issue 3, January 30, 2018  Today’s turbulent healthcare industry offers many challenges for healthcare executives. Despite this, providers can create significant value that will help them to build their healthcare businesses, finance growth, and ultimately sell their companies for the best price. Seven key value drivers for…

READ MORE

7 Ways Buyers Can Easily Blow Healthcare Transactions

By Tom Schramski, Managing Partner Volume 5 Issue 2, January 16, 2018  Much of the literature on failed healthcare transactions focuses on seller-related problems – unrealistic expectations, poor margins, a troubled market, and even fraudulent financial reporting. But it takes two to tango and buyers have their role. Sometimes, they lack other-awareness in the following ways: Not…

READ MORE